Logo image of OMI

OWENS & MINOR INC (OMI) Stock Fundamental Analysis

USA - NYSE:OMI - US6907321029 - Common Stock

2.8 USD
-0.13 (-4.44%)
Last: 11/14/2025, 8:14:10 PM
2.82 USD
+0.02 (+0.71%)
After Hours: 11/14/2025, 8:14:10 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OMI. OMI was compared to 100 industry peers in the Health Care Providers & Services industry. While OMI is still in line with the averages on profitability rating, there are concerns on its financial health. OMI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OMI had positive earnings in the past year.
In the past year OMI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
OMI had a positive operating cash flow in each of the past 5 years.
OMI Yearly Net Income VS EBIT VS OCF VS FCFOMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

OMI has a Return On Assets of -33.21%. This is amonst the worse of the industry: OMI underperforms 86.00% of its industry peers.
OMI's Return On Invested Capital of 10.36% is amongst the best of the industry. OMI outperforms 82.00% of its industry peers.
OMI had an Average Return On Invested Capital over the past 3 years of 6.37%. This is below the industry average of 9.40%.
The last Return On Invested Capital (10.36%) for OMI is above the 3 year average (6.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROIC 10.36%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
OMI Yearly ROA, ROE, ROICOMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

OMI's Operating Margin of 3.07% is in line compared to the rest of the industry. OMI outperforms 55.00% of its industry peers.
In the last couple of years the Operating Margin of OMI has grown nicely.
Looking at the Gross Margin, with a value of 26.13%, OMI is in line with its industry, outperforming 52.00% of the companies in the same industry.
OMI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 26.13%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
OMI Yearly Profit, Operating, Gross MarginsOMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), OMI is creating some value.
Compared to 1 year ago, OMI has more shares outstanding
OMI has more shares outstanding than it did 5 years ago.
OMI has a better debt/assets ratio than last year.
OMI Yearly Shares OutstandingOMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OMI Yearly Total Debt VS Total AssetsOMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

OMI has an Altman-Z score of 1.41. This is a bad value and indicates that OMI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.41, OMI is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACC1.56
WACC6.64%
OMI Yearly LT Debt VS Equity VS FCFOMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.86 indicates that OMI may have some problems paying its short term obligations.
OMI's Current ratio of 0.86 is on the low side compared to the rest of the industry. OMI is outperformed by 80.00% of its industry peers.
OMI has a Quick Ratio of 0.86. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OMI (0.84) is worse than 73.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.84
OMI Yearly Current Assets VS Current LiabilitesOMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

The earnings per share for OMI have decreased strongly by -22.29% in the last year.
OMI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.10% yearly.
The Revenue for OMI has decreased by -37.09% in the past year. This is quite bad
OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%

3.2 Future

Based on estimates for the next years, OMI will show a decrease in Earnings Per Share. The EPS will decrease by -1.16% on average per year.
The Revenue is expected to decrease by -26.97% on average over the next years. This is quite bad
EPS Next Y-31.11%
EPS Next 2Y-20.17%
EPS Next 3Y-9.79%
EPS Next 5Y-1.16%
Revenue Next Year-73.87%
Revenue Next 2Y-49.96%
Revenue Next 3Y-35.61%
Revenue Next 5Y-26.97%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OMI Yearly Revenue VS EstimatesOMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
OMI Yearly EPS VS EstimatesOMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.17, which indicates a rather cheap valuation of OMI.
Compared to the rest of the industry, the Price/Earnings ratio of OMI indicates a rather cheap valuation: OMI is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, OMI is valued rather cheaply.
The Price/Forward Earnings ratio is 2.89, which indicates a rather cheap valuation of OMI.
Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 99.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OMI to the average of the S&P500 Index (34.59), we can say OMI is valued rather cheaply.
Industry RankSector Rank
PE 2.17
Fwd PE 2.89
OMI Price Earnings VS Forward Price EarningsOMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

92.00% of the companies in the same industry are more expensive than OMI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.04
OMI Per share dataOMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as OMI's earnings are expected to decrease with -9.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-20.17%
EPS Next 3Y-9.79%

0

5. Dividend

5.1 Amount

OMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OWENS & MINOR INC

NYSE:OMI (11/14/2025, 8:14:10 PM)

After market: 2.82 +0.02 (+0.71%)

2.8

-0.13 (-4.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-26 2026-02-26/amc
Inst Owners100.37%
Inst Owner Change-0.36%
Ins Owners3.61%
Ins Owner Change-0.31%
Market Cap216.27M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Analysts51.67
Price Target6.3 (125%)
Short Float %11.32%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-6.28%
Max EPS beat(2)6.69%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)4.92%
EPS beat(12)10
Avg EPS beat(12)14.96%
EPS beat(16)13
Avg EPS beat(16)13.17%
Revenue beat(2)0
Avg Revenue beat(2)-21.34%
Min Revenue beat(2)-39.15%
Max Revenue beat(2)-3.53%
Revenue beat(4)0
Avg Revenue beat(4)-11.31%
Min Revenue beat(4)-39.15%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-5.89%
Revenue beat(12)4
Avg Revenue beat(12)-3.26%
Revenue beat(16)7
Avg Revenue beat(16)-2.2%
PT rev (1m)0.57%
PT rev (3m)-38.25%
EPS NQ rev (1m)-4.96%
EPS NQ rev (3m)-65.15%
EPS NY rev (1m)1.45%
EPS NY rev (3m)-37.45%
Revenue NQ rev (1m)-37.45%
Revenue NQ rev (3m)-74.6%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)-74.57%
Valuation
Industry RankSector Rank
PE 2.17
Fwd PE 2.89
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 5.04
EPS(TTM)1.29
EY46.07%
EPS(NY)0.97
Fwd EY34.6%
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS86.84
BVpS-5.56
TBVpS-23.61
PEG (NY)N/A
PEG (5Y)0.1
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROCE 13.12%
ROIC 10.36%
ROICexc 10.59%
ROICexgc 113.35%
OM 3.07%
PM (TTM) N/A
GM 26.13%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3Y-4.88%
ROICexgc growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score2
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 105.46%
Cap/Sales 3.93%
Interest Coverage 1.54
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.84
Altman-Z 1.41
F-Score2
WACC6.64%
ROIC/WACC1.56
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.11%
EPS Next 2Y-20.17%
EPS Next 3Y-9.79%
EPS Next 5Y-1.16%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-73.87%
Revenue Next 2Y-49.96%
Revenue Next 3Y-35.61%
Revenue Next 5Y-26.97%
EBIT growth 1Y-30.13%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year24.04%
EBIT Next 3Y7.75%
EBIT Next 5YN/A
FCF growth 1Y-170.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.82%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%

OWENS & MINOR INC / OMI FAQ

Can you provide the ChartMill fundamental rating for OWENS & MINOR INC?

ChartMill assigns a fundamental rating of 3 / 10 to OMI.


What is the valuation status for OMI stock?

ChartMill assigns a valuation rating of 6 / 10 to OWENS & MINOR INC (OMI). This can be considered as Fairly Valued.


What is the profitability of OMI stock?

OWENS & MINOR INC (OMI) has a profitability rating of 4 / 10.


What is the valuation of OWENS & MINOR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for OWENS & MINOR INC (OMI) is 2.17 and the Price/Book (PB) ratio is -0.5.


What is the financial health of OWENS & MINOR INC (OMI) stock?

The financial health rating of OWENS & MINOR INC (OMI) is 2 / 10.